Lucibel SA

EPA:ALUCI.PA

0.175 (EUR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 4.0295.0064.1714.0064.0965.0515.2234.9753.18610.36510.5149.82310.00414.16312.97514.60613.51612.55512.01212.5888.9545.3865.3861.5891.5891.5891.589
Cost of Revenue 1.5753.4073.5583.7881.8884.815.284.8683.4329.1045.0754.4944.8146.8476.4537.3817.1936.7275.9816.8545.1292.8762.8760.7850.7850.7850.785
Gross Profit 2.4541.5990.6130.2182.2080.241-0.0570.107-0.2461.2615.4395.3295.197.3166.5227.2256.3235.8286.0315.7343.8252.512.510.8040.8040.8040.804
Gross Profit Ratio 0.6090.3190.1470.0540.5390.048-0.0110.022-0.0770.1220.5170.5430.5190.5170.5030.4950.4680.4640.5020.4560.4270.4660.4660.5060.5060.5060.506
Reseach & Development Expenses 0.1310.1310.09100.10200.10000.0080.0540.0070.0120.010.0190.0290.1330.0640.0670.158-0.119-0.119-0.041-0.041-0.041-0.041
General & Administrative Expenses 2.64101.21303.2971.5621.0811.2770.722.246.535.8625.7646.3946.7288.8469.40810.62510.1231.6441.371.371.371.0031.0031.0031.003
Selling & Marketing Expenses 0.25800.30700.2350.0820.1070.0750.0770.1410.1610.1210.1010.1040.0670.0830.1790.2720.3330.1650.1710.0840.0840.0910.0910.0910.091
SG&A 2.8991.5281.4231.5653.5321.6441.1881.3520.7972.3816.6915.9835.8656.4986.7958.9299.58710.89710.4568.8446.721.4541.4541.0941.0941.0941.094
Other Expenses 0.741-0.074-0.9440.0740-0.0840.204-0.171-0.063-0.033000000000-1.453-0.95-0.95-0.95-0.824-0.824-0.824-0.824
Operating Expenses 2.631.6022.3671.4913.6951.7280.9841.5230.862.4146.2546.2375.6947.3097.1169.6059.91511.2110.8679.0847.110.3850.3850.2290.2290.2290.229
Operating Income -0.153-0.003-1.754-1.273-1.798-1.487-1.041-1.416-1.106-1.153-1.723-1.142-0.5750.24-0.037-3.316-3.171-5.527-4.762-3.238-3.212-1.657-1.657-1.663-1.663-1.663-1.663
Operating Income Ratio -0.038-0.001-0.421-0.318-0.439-0.294-0.199-0.285-0.347-0.111-0.164-0.116-0.0570.017-0.003-0.227-0.235-0.44-0.396-0.257-0.359-0.308-0.308-1.046-1.046-1.046-1.046
Total Other Income Expenses Net -0.010.2220.0790.6210.2920.051-0.3030.18-9.211-0.4520.8710.182-0.009-0.356-0.7020.739-0.548-0.002-0.786-0.712-0.133-0.167-0.167-0.009-0.009-0.009-0.009
Income Before Tax -0.1630.219-1.675-0.652-1.506-1.436-1.344-1.236-10.317-1.605-0.852-0.96-0.584-0.116-0.739-2.577-3.719-5.529-5.548-3.95-3.345-1.824-1.824-1.672-1.672-1.672-1.672
Income Before Tax Ratio -0.040.044-0.402-0.163-0.368-0.284-0.257-0.248-3.238-0.155-0.081-0.098-0.058-0.008-0.057-0.176-0.275-0.44-0.462-0.314-0.374-0.339-0.339-1.052-1.052-1.052-1.052
Income Tax Expense 0.0570.04-0.0400.0160-0.006-0.0050.0860.00500.00200.0140.0160.0340.0050.3560.850.0450.01-0.014-0.014-0.001-0.001-0.001-0.001
Net Income -0.1060.179-1.635-0.652-1.49-1.436-1.338-1.231-10.403-1.609-0.852-0.962-0.584-0.093-0.892-2.59-3.714-5.159-4.701-3.909-3.324-1.81-1.81-1.671-1.671-1.671-1.671
Net Income Ratio -0.0260.036-0.392-0.163-0.364-0.284-0.256-0.247-3.265-0.155-0.081-0.098-0.058-0.007-0.069-0.177-0.275-0.411-0.391-0.311-0.371-0.336-0.336-1.051-1.051-1.051-1.051
EPS -0.0060.01-0.098-0.042-0.1-0.095-0.092-0.085-0.72-0.11-0.081-0.091-0.06-0.011-0.1-0.3-0.48-0.7-0.75-0.68-0.63-0.33-0.33-0.4-0.4-0.4-0.4
EPS Diluted -0.0060.01-0.098-0.042-0.1-0.095-0.092-0.085-0.72-0.11-0.081-0.091-0.06-0.01-0.1-0.3-0.48-0.7-0.75-0.68-0.63-0.33-0.33-0.4-0.4-0.4-0.4
EBITDA -0.0490.238-1.553-1.071-1.299-1.308-0.693-1.075-0.652-0.668-1.346-0.77-0.1940.7390.297-2.895-2.619-5.063-4.534-3.15-2.902-1.496-1.496-1.498-1.498-1.498-1.498
EBITDA Ratio -0.0120.048-0.372-0.267-0.317-0.259-0.133-0.216-0.205-0.064-0.128-0.078-0.0190.0520.023-0.198-0.194-0.403-0.377-0.25-0.324-0.278-0.278-0.942-0.942-0.942-0.942